Promising tissue valve Tech Blocks the build-up of calcium
News Highlights: Promising tissue valve Tech Blocks the build-up of calcium
According to the COMMENCE researchers, a tissue valve built for less valve structural deterioration showed favorable safety and hemodynamic performance after 5 years of surgical aortic valve replacement (SAVR).
Surgical valves mounted with Resilia (a patented bovine pericardial tissue, from Edwards Lifesciences, formulated to reduce the calcification that often leads to valve dysfunction) have been associated with ‘quite satisfactory’ safety in 471 patients with a 30-day mortality and stroke rates of 1.2% and 1.6%, respectively, reported Joseph Bavaria, MD, of the University of Pennsylvania Hospital in Philadelphia.